Klenk Jeffrey P.

EVP Jeffrey Klenk sells 6,413 TRV shares at $305.06; holdings reduced 51.4% to 6,075 shares post-transaction.

Klenk executed a substantial single transaction selling 6,413 shares at $305.06 on 2026-04-20, reducing his TRV holdings by 51.4% from 12,488 to 6,075 shares. Against current price of $301.42, the transaction price represents a modest premium; relative to the 52-week high of $312.03, the sale occurred near peak valuation (only -3.4% below range ceiling). His prior three measurable same-ticker sales at TRV show mixed timing results (2 of 3 well-timed at the 90-day mark, but one at 2025-05-29 declined further, and the most recent 2026-01-23 sale showed strong 30-day performance with 90d outcome not yet measurable). At a company-wide level, TRV's fundamentals remain solid with $11.9B revenue, $1.7B net income, +5.2% annual growth, and a low P/E of 8.43. The magnitude of this reduction—roughly half his accumulated position—marks a material portfolio adjustment by a senior executive, though the pattern of his same-ticker activity lacks strong predictive consistency to signal broader forward outlook.

EVP Klenk sold 16,712 TRV shares at $279.77 for $4.7M, reducing stake 73.3%

Klenk Jeffrey P., Executive Vice President & President of Bond & Special Insurance, executed a substantial open-market sale of 16,712 shares ($4,675,593.12 total value) on 2026-01-23 at $279.77 per share, reducing his holdings from 22,787 shares to 6,075 shares—a 73.3% reduction. His prior sales at TRV showed mixed timing outcomes: two of three prior trades at this ticker subsequently declined over 90 days (-3.4% and -3.6%), while one appreciated (+4.0%), yielding 66.67% well-timed outcomes at the 90-day mark. The stock currently trades at $281.71, up 5.1% over 90 days and down 3.6% over 30 days from the transaction date. With TRV trading at a P/E of 10.70 and the company posting $12.5B in latest-quarter revenue with strong 12.2% annual growth and $1.9B net income, the sale reflects significant portfolio repositioning by a senior executive rather than fundamental concern, though the magnitude of the stake reduction warrants monitoring of any subsequent insider activity or material disclosures.

EVP Jeffrey P. Klenk sells 15,180 shares of TRV for $4,142,183.75; reduces holdings from 21,255 to 6,075 shares (-71.4%).

Jeffrey P. Klenk, EVP & President of Bond & Special Insurance at Travelers, executed two separate sales totaling 15,180 shares for $4,142,183.75 on May 29, 2025, at a blended average price of $272.87. This represents a dramatic 71.4% reduction in his disclosed holdings, leaving him with only 6,075 shares post-transaction. The sales occurred near Travelers' 52-week high of $275.88, with the stock currently at $275.70 and up 4.4% over 30 days and 6.7% over 90 days. Klenk's cross-ticker track record shows only 1 prior open-market sell with a 90-day return of +0.8% and a 0% well-timed rate, while his single prior sale at TRV in January 2024 was followed by a +0.8% 90-day return (not well-timed). The substantial reduction in his position relative to his prior holdings at a near-52-week-high price point is noteworthy given Travelers' solid fundamentals (P/E of 14.63, $11.8B revenue, and +12.2% annual revenue growth), though the magnitude of the sale warrants examination of any non-discretionary factors or disclosure circumstances.